Lack of Evidence for Association between Endothelial Nitric Oxide Synthase Gene Polymorphisms and Coronary Artery Disease in the Australian Caucasian Population
Restricted accessResearch articleFirst published online August, 2001
Lack of Evidence for Association between Endothelial Nitric Oxide Synthase Gene Polymorphisms and Coronary Artery Disease in the Australian Caucasian Population
Background Genetic polymorphism in the gene for endothelial nitric oxide synthase (eNOS) has been identified as a potential risk factor for the development of premature coronary artery disease (CAD). We determined whether the eNOS 4ab, G894T, and T-786C polymorphisms are associated with premature coronary artery disease.
Design A case-control study.
Methods PCR-based assays were used to compare the frequency of eNOS gene polymorphisms in 573 Caucasian subjects aged under 50 years presenting with symptomatic CAD and documented by coronary angiography, with or without myocardial infarction, to that of 624 similarly aged community controls without a history of symptomatic CAD.
Results We found no difference in the frequency of 4ab genotypes between cases and controls: In the CAD subjects, the 4aa, 4ab, and 4bb genotype frequencies were 1.9%, 24.3% and 73.8% respectively, compared to 2.2%, 25.5% and 72.3% respectively for the controls. There was also no significant difference between cases and controls in the frequency of any allele (4a/4b, 894G/894T, −786C/-786T), or genotype for any of the polymorphisms. Similarly, logistic regression analysis showed no evidence for an association of the polymorphisms with premature CAD or myocardial infarction or any indication of an interaction between the polymorphisms and other CAD risk factors, including smoking.
Conclusions In a large case-control study, and in contrast to some earlier positive findings by others, we have found no evidence for an association between several eNOS gene polymorphisms and premature CAD in an Australian Caucasian population.
MoncadaSHiggsEA.Molecular mechanisms and therapeutic strategies related to nitric oxide. FASEB J1995; 9:1319–1330.
2.
HarrisonDG.Cellular and molecular mechanisms of endothelial cell dysfunction. J Clin Invest1997; 100:2153–2157.
3.
WangXLSimASBadenhopRFMcCredieRMWilckenDEL.A smoking-dependent risk of coronary artery disease associated with a polymorphism of the endothelial nitric oxide synthase gene. Nature Med1996; 2:41–45.
4.
IchiharaSYamadaYFujimuraTNakashimaNYokotaM.Association of a polymorphism of the endothelial constitutive nitric oxide synthase gene with myocardial infarction in the Japanese population. Am J Cardiol1998; 81:83–86.
5.
HooperWCLallyCAustinHBensonJDilleyAWengerNK et al. The relationship between polymorphisms in the endothelial cell nitric oxide synthase gene and the platelet GpIIIa gene with myocardial infarction and venous thrombosis in African Americans. Chest1999; 116:880–886.
6.
WangXLMahaneyMCSimASWangJWangJBlangeroJ et al. Genetic contribution of the endothelial constitutive nitric oxide synthase gene to plasma nitric oxide levels. Arterioscler Thromb Vasc Biol1997; 17:3147–3153.
7.
TsukadaTYokoyamaKAraiTTakemotoFHaraSYamadaA et al. Evidence of association of the ecNOS gene polymorphism with plasma NO metabolite levels in humans. Biochem Biophys Res Comm1998; 245:190–193.
8.
HibiKIshigamiTTamuraKMizushimaSNyuiNFujitaT et al. Endothelial nitric oxide synthase gene polymorphism and acute myocardial infarction. Hypertension1998; 32:521–526.
9.
HingoraniADLiangCFFatibeneJLyonAMonteithSParsonsA et al. A common variant of the endothelial nitric oxide synthase (Glu298 ⇉ Asp) is a major risk factor for coronary artery disease in the UK. Circulation1999; 100:1515–1520.
10.
YoonYSongJHongSHKimJQ.Plasma nitric oxide concentrations and nitric oxide synthase gene polymorphisms in coronary artery disease. Clin Chem2000; 46:1626–1630.
11.
SiguschHHSurberRLehmannMHSurberSWeberJHenkeA et al. Lack of association between 27-bp repeat polymorphism in intron 4 of the endothelial nitric oxide synthase gene and the risk of coronary artery disease. Scan J Clin Lab Invest2000; 60:229–235.
12.
PulkkinenAViitanenLKareinenALehtosSVauhkonenILaaksoM.Intron 4 polymorphism of the endothelial nitric oxide synthase gene is associated with elevated blood pressure in type 2 diabetic patients with coronary heart disease. J Mol Med2000; 78:372–379.
13.
ShimasakiYYasueHYoshimuraMNakayamaMKugiyamaKOgawaH et al. Association of the missense Glu298Asp variant of the endothelial nitric oxide synthase gene with myocardial infarction. J Am Coll Cardiol1998; 31:1506–1510.
14.
PoirierOMaoCMalletCNicaudVHerrmannSMEvansA et al. Polymorphisms of the endothelial nitric oxide synthase gene – no consistent association with myocardial infarction in the ECTIM study. Eur J Clin Invest1999; 29:284–290.
15.
LiyouNSimonsLFriedlanderYSimonsJMcCallumJO'ShaughnessyK et al Coronary artery disease is not associated with the E298 ⇉ D variant of the constitutive, endothelial nitric oxide synthase gene. Clin Genet1998; 54: 528–529.
16.
NakayamaMYasueHYoshimuraMShimasakiYKugiyamaKOgawaH et al. T-786C mutation in the 5-flanking region of the endothelial nitric oxide synthase gene that is associated with coronary spasm. Circulation1999; 99:2864–2870.
17.
SimASWangJWilckenDWangXL.MspI polymorphism in the promoter of the human endothelial constitutive NO synthase gene in Australian Caucasian population. Mol Genet Metab1998; 65:62.
18.
KunkelLMSmithKDBoyerSHBorgaonkarDSWachtelSSMillerOJ et al. Analysis of human Y-chromosome specific reiterated DNA in chromosome variants. Proc Natl Acad Sci USA1977; 74:1245–1249.
19.
FowkesFGRLeeAJHauCMCookeAConnorJMLoweGDO.Methylene tetrahydrofolate reductase (MTHFR) and nitric oxide synthase (ecNOS) genes and risks of peripheral arterial disease and coronary heart disease: Edinburgh artery study. Atherosclerosis2000; 150:179–185.
20.
WeverRMFLuscherTFCosentinoFRabelinkTJ.Atherosclerosis and the two faces of endothelial nitric oxide synthase. Circulation1998; 97:108–112.
21.
WangXLSimASWangMXMurrellGACTrudingerBWangJ.Genotype dependent and cigarette specific effects on endothelial nitric oxide synthase gene expression and enzyme activity. FEBS Lett2000; 471:45–50.
22.
CaiHWilckenDELWangXL.The Glu-298 ⇉ Asp (894G ⇉ T) mutation at exon 7 of the endothelial nitric oxide synthase gene and coronary artery disease. J Mol Med1999; 77:511–514.
23.
SchneiderMPErdmannJDellesCFleckERegitz-ZagrosekVSchmiederRE.Functional gene testing of the Glu298Asp polymorphism of the endothelial NO synthase. J Hypertens2000; 18:1767–1773.
